è¯券时报eå…¬å¸è®¯ï¼Œå® 丽迪(300905)1月14日晚间公告，2024å¹´é¢ "计实现归属于上市公å¸è'¡ä¸œçš"净利润1.1亿元—1.18亿å… ƒï¼Œå Œæ¯"增长10.57%—18.61%。 å…¬å¸æŒç»ç ӌ'创新和市场拓展，实现了产å"å"质和销é‡çš"åξ å ‡ã€' 报告期内，公å¸è ¥ä¸šæ"¶å…¥å Œæ¯"增长约14%。 å…¬å¸äº§å"毛利率稳ä¸æœ‰å ‡ï¼Œæ¯›åˆ©é¢ 较去年å ŒæœŸå¢žåŠ 了约4300万å… ƒï¼Œå Œæ¯"增长约20%。 ...

Financial Performance Expectations - The company expects a net profit attributable to shareholders of approximately 11,000 million yuan for 2024, representing a year-on-year increase of 10.57%-18.61%[3] - The net profit after deducting non-recurring gains and losses is projected to be around 9,700 million yuan, reflecting a year-on-year growth of 10.68%-18.67%[3] - The company's operating revenue is expected to increase by approximately 14% year-on-year[5] - Gross profit margin has shown a steady increase, with gross profit amounting to about 4,300 million yuan, a year-on-year increase of approximately 20%[5] Impact of Non-Recurring Items - Non-recurring gains and losses are estimated to impact net profit attributable to shareholders by approximately 1,385 million yuan[6] - The company implemented an employee stock incentive plan, incurring approximately 2,459 million yuan in share-based payment expenses, which is expected to impact net profit attributable to shareholders by about 2,156 million yuan[5] Communication and Compliance - The company has communicated with the accounting firm regarding the earnings forecast, and there are no significant discrepancies[4] - The earnings forecast is based on preliminary calculations by the company's finance department, with final figures to be disclosed in the formal 2024 annual report[7] - The company emphasizes compliance with legal regulations for timely information disclosure to mitigate investment risks[7] Reporting Period - The reporting period for the earnings forecast is from January 1, 2024, to December 31, 2024[3]

证券代码：300905 证券简称：宝丽迪 公告编号：2024-073 苏州宝丽迪材料科技股份有限公司 关于变更签字会计师的公告 近日，公司收到立信所出具的《关于签字注册会计师变更的说明》，现将相 关情况公告如下： 一、签字会计师变更情况 立信所作为公司 2024 年度财务审计机构，原委派丁陈隆先生（项目合伙人）、 吴金婉女士作为签字注册会计师，徐立群先生作为项目质量控制复核人共同为公 司提供审计服务。由于立信所内部工作调整，现项目合伙人由丁陈隆先生变更为 罗丹女士。本次变更后，为公司提供 2024 年审计服务的签字注册会计师为罗丹女 士（项目合伙人）、吴金婉女士，项目质量控制复核人为徐立群先生。 二、本次变更签字会计师信息 （一）基本信息 罗丹女士，2014 年成为中国注册会计师，自 2011 年起开始从事上市公司审 计工作，先后为多家上市公司提供服务，2014 年开始在立信所执业，具备专业胜 任能力。 项目合伙人近三年从业情况： 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 苏州宝丽迪材料科技股份有限公司（以下简称"公司"）于 2024 年 3 月 28 ...

证券代码：300905 证券简称：宝丽迪 公告编号：2024-072 苏州宝丽迪材料科技股份有限公司 根据中国证券登记结算有限责任公司出具的《证券过户登记确认书》，上述 协议转让股份已于 2024 年 12 月 9 日办理完成过户登记手续，合计过户数量 9,500,000 股，占公司总股本的5.34%，股份性质为无限售流通股。 本次协议转让股份过户完成后，徐闻达先生及其一致行动人持有公司股份 81,922,088 股，占公司总股本的 46.07%，仍为公司控股股东；云南信托持有公 司股份 9,500,000 股，占公司总股本比例的 5.34%，成为公司持股 5%以上股东， 位列公司前十大股东。 | 股东及其一致行动人 | 权益变动前 | | 变动数量 | 权益变动后 | | | --- | --- | --- | --- | --- | --- | | | 持股数量（股） | 持股比例 | | 持股数量（股） | 持股比例 | | 徐闻达 | 38,262,226 | 21.52% | -9,500,000 | 28,762,226 | 16.18% | | 徐毅明 | 11,098,266 | 6.24% ...

证券代码：300905 证券简称：宝丽迪 公告编号：2024-071 苏州宝丽迪材料科技股份有限公司 关于公司控股股东、实际控制人 拟协议转让公司部分股份暨签署补充协议的公告 公司实际控制人徐闻达保证向本公司提供的信息内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、本次协议转让的基本情况 苏州宝丽迪材料科技股份有限公司（以下简称"公司"）于 2024 年 9 月 27 日收到控股股东徐闻达先生的通知，徐闻达先生与云南国际信托有限公司（ 代表云南信托-开睿210号单一资金信托）即证券账户名称为"云南国际信托有限 公司-云南信托-开睿210号单一资金信托"（以下简称"云南信托"）于 2024 年 9 月 27日签署了《股份转让协议》，约定徐闻达先生拟以协议转让方式将其持 有的公司 9,500,000 股股份（占公司总股本的 5.34%）转让给云南信托。具体内 容详见公司于 2024 年 9 月 30 日在巨潮资讯网 （www.cninfo.com.cn）披露 的《关于公司控股股东、实际控制人拟协议转 ...

关于公司高级管理人员减持股份的预披露公告 公司高级管理人员陈劲松先生向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持有本公司股份 10,756,306 股（占本公司总股本比例 6.0491%）的高级管 理人员陈劲松先生计划自本公告披露之日起十五个交易日后的三个月内以集中竞 价交易、大宗交易方式减持本公司股份 1,500,000 股（占本公司总股本比例 0.8436%）。 证券代码：300905 证券简称：宝丽迪 公告编号：2024-070 苏州宝丽迪材料科技股份有限公司 5、减持期间：自本公告披露之日起十五个交易日后的三个月内（即 2024 年 11 月 22 日至 2025 年 1 月 21 日，根据中国证监会及深圳证券交易所相关规定禁止 减持的期间除外） 6、减持价格：根据市场价格确定 苏州宝丽迪材料科技股份有限公司（以下简称"公司"）于近日收到公司高 级管理人员陈劲松先生出具的《股份减持计划告知函》，现将有关情况公告如下： | 股东名称 | 股东情况 | 持股数量（股） | 占公司总股本的比 ...

证券代码：300905 证券简称：宝丽迪 公告编号：2024-066 二、董事会会议审议情况 与会董事经过表决，审议并通过了以下议案： （一）审议通过《关于公司 2024 年第三季度报告的议案》 公司《2024 年第三季度报告》的编制和审议程序符合法律、行政法规和中国 证监会的规定，报告内容真实、准确、完整地反映了公司的实际情况，不存在任 何虚假记载、误导性陈述或者重大遗漏。公司董事会审计委员会及独立董事专门 会议已审议通过了该议案。 具体内容详见公司同日披露于巨潮资讯网（www.cninfo.com.cn）的公司 《2024 年第三季度报告》（公告编号：2024-069）。 表决结果：同意 7 票、反对 0 票、弃权 0 票。 苏州宝丽迪材料科技股份有限公司 第三届董事会第六次会议决议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 苏州宝丽迪材料科技股份有限公司（以下简称"公司"）第三届董事会第六 次会议于 2024 年 10 月 22 日上午 9:30 以现场会议的形式召开。本次会议通知于 2024 年 10 月 11 日以 ...

经审议，监事会认为：公司《2024 年第三季度报告》的编制和审议程序符合 法律、行政法规和中国证监会的规定，报告内容真实、准确、完整地反映了公司 的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。 证券代码：300905 证券简称：宝丽迪 公告编号：2024-067 苏州宝丽迪材料科技股份有限公司 第三届监事会第五次会议决议的公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 苏州宝丽迪材料科技股份有限公司（以下简称"公司"）第三届监事会第五 次会议于 2024 年 10 月 22 日下午 2 点以现场会议的形式召开。本次会议通知于 2024 年 10 月 11 日以微信、电话、邮件等方式通知送达公司全体监事。公司应 出席监事 3 名，实际出席会议监事 3 名。公司董事会秘书列席了会议，会议由监 事会主席付洋女士主持。本次会议的召集、召开程序符合有关法律法规以及《公 司章程》的规定。 二、监事会会议审议情况 （一）审议通过《关于公司 2024 年第三季度报告的议案》 监事会 2024 年 10 月 22 日 具体内容详见公司同日 ...

Financial Performance - The company's revenue for Q3 2024 was CNY 345,616,872.70, a decrease of 2.29% compared to the same period last year, while year-to-date revenue reached CNY 1,011,468,711.50, an increase of 22.63%[3] - Net profit attributable to shareholders for Q3 2024 was CNY 25,469,227.82, down 23.84% year-on-year, with a year-to-date net profit of CNY 80,869,522.45, reflecting an increase of 8.96%[3] - The company's basic earnings per share for Q3 2024 was CNY 0.14, a decrease of 26.32% compared to the same period last year[3] - The total operating revenue for the third quarter of 2024 was CNY 1,011,468,711.50, an increase of 22.6% compared to CNY 824,811,386.50 in the same period last year[17] - The company's operating profit for Q3 2024 was ¥95,731,485.43, compared to ¥89,520,588.78 in Q3 2023, marking an increase of around 6.5%[18] - The total profit for Q3 2024 was ¥95,730,548.96, an increase from ¥89,032,093.05 in Q3 2023, representing a growth of approximately 7.5%[18] Cash Flow - The net cash flow from operating activities for the year-to-date period was CNY 86,450,336.97, showing a significant increase of 238.79%[3] - The net cash flow from operating activities for Q3 2024 was CNY 86,450,336.97, a significant increase from CNY 25,517,324.89 in Q3 2023, reflecting improved operational efficiency[21] - The total cash inflow from investment activities was CNY 693,533,621.51, compared to CNY 99,304,458.68 in the same period last year, indicating a strong recovery in investment returns[21] - The cash outflow for investment activities was CNY 718,845,191.02, up from CNY 297,159,869.97 in Q3 2023, primarily due to increased capital expenditures[21] - The net cash flow from financing activities was CNY -43,851,696.41, a decrease from CNY 199,064,784.86 in Q3 2023, reflecting higher dividend payments and debt repayments[21] - The ending balance of cash and cash equivalents increased to CNY 159,601,458.83, up from CNY 123,719,463.55 at the end of Q3 2023, showing improved liquidity[22] Expenses - Research and development expenses for Q3 2024 amounted to CNY 38,654,144.52, an increase of 34.97% year-on-year, reflecting the company's commitment to enhancing its R&D capabilities[8] - The company reported a significant increase in sales expenses, which reached CNY 10,783,525.66, up 58.94% year-on-year due to new stock-based compensation for sales personnel[8] - Total operating costs for Q3 2024 were ¥929,457,810.04, up from ¥831,535,347.17 in Q3 2023, indicating a year-over-year increase of about 11.8%[18] - Employee compensation payments rose to CNY 83,433,712.42 from CNY 68,873,129.02, reflecting a focus on talent retention and workforce expansion[21] Assets and Liabilities - The total assets at the end of Q3 2024 were CNY 2,064,223,596.06, representing a growth of 1.77% compared to the end of the previous year[3] - Total liabilities amounted to CNY 208,528,485.28, slightly up from CNY 202,747,924.20, representing an increase of 2.9%[17] - The company's equity attributable to shareholders increased to CNY 1,829,578,191.26 from CNY 1,808,055,494.03, a rise of 1.2%[17] - Accounts receivable increased to CNY 201,469,831.21 from CNY 159,797,424.02, reflecting a growth of 26.1%[16] - Inventory rose to CNY 198,599,292.08, up from CNY 177,692,401.27, indicating an increase of 11.7%[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 21,277[12] - Xu Wenda holds 21.52% of shares, totaling 38,262,226 shares[12] - Xu Yiming holds 6.24% of shares, totaling 11,098,266 shares[12] - The company has a significant shareholder relationship, with Xu Yiming and Xu Wenda being father and son, both acting as controlling shareholders[12] - The total number of restricted shares at the beginning of the period was 744,042,692, with 691,705,638 shares released during the period[14] - Xu Wenda's restricted shares remain at 28,696,669, with no shares released[14] - The company has a total of 53,332,338 restricted shares remaining after the release[14] - The total number of shares held by the top 10 shareholders represents a significant portion of the company's equity[12] Other Financial Metrics - The company reported a net exchange loss of ¥595,200.63 in Q3 2024, compared to a gain of ¥407,021.98 in Q3 2023[19] - The financial expenses for Q3 2024 were reported as -¥2,793,466.65, compared to -¥85,548.78 in Q3 2023, indicating a significant change in financial costs[18] - The company has plans for market expansion and new product development, although specific details were not disclosed in the report[16] - The total comprehensive income for Q3 2024 was ¥78,529,829.00, compared to ¥74,722,690.20 in Q3 2023, indicating a growth of about 5.4%[19]